Liver fibrosis is independent of methotrexate use in patients with moderate-to-severe psoriasis

被引：0
|
作者：
Babakinejad, Parastoo [1 ]
Lapsley, Rebecca [1 ]
Foster, Lara [2 ]
McPherson, Stuart [1 ]
Pearce, Mark [2 ]
Reynolds, Nick [1 ]
Slack, Emma [2 ]
Weatherhead, Sophie [1 ]
Hampton, Philip [1 ]
机构：
[1] Royal Victoria Infirm, Newcastle Upon Tyne, Tyne & Wear, England
[2] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 188卷
关键词：
D O I：
10.1093/bjd/ljad113.096
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P68
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Risankizumab in moderate-to-severe plaque psoriasis
    Serrano, Linda
    Maloney, Victoria
    Gordon, Kenneth B.
    IMMUNOTHERAPY, 2019, 11 (16) : 1357 - 1370
  • [32] Managing Moderate-to-Severe Psoriasis in the Elderly
    Balato, Nicola
    Patruno, Cataldo
    Napolitano, Maddalena
    Patri, Angela
    Ayala, Fabio
    Scarpa, Raffaele
    DRUGS & AGING, 2014, 31 (04) : 233 - 238
  • [33] Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis
    María C. Ovejero-Benito
    Ester Muñoz-Aceituno
    Alejandra Reolid
    Miriam Saiz-Rodríguez
    Francisco Abad-Santos
    Esteban Daudén
    American Journal of Clinical Dermatology, 2018, 19 : 209 - 222
  • [34] Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis
    Ovejero-Benito, Maria C.
    Munoz-Aceituno, Ester
    Reolid, Alejandra
    Saiz-Rodriguez, Miriam
    Abad-Santos, Francisco
    Dauden, Esteban
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (02) : 209 - 222
  • [35] Treatment of moderate-to-severe plaque psoriasis
    Salgo, R.
    Thaci, D.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2009, 144 (06): : 701 - 711
  • [36] A COMPARISON OF EFFICACY AND ADVERSE REACTIONS BETWEEN METHOTREXATE AND CYCLOSPORINE A IN MODERATE-TO-SEVERE PLAQUE PSORIASIS
    Kim, Sang Yub
    Yun, Sook Jung
    Lee, Jee-Bum
    Kim, Seoung-Jin
    Won, Young Ho
    Lee, Seung-Chul
    JOURNAL OF DERMATOLOGY, 2014, 41 : 12 - 12
  • [37] Improvement in the psoriasis symptom inventory in moderate-to-severe psoriasis patients on etanercept or adalimumab
    Patel, Mira
    Martin, Mona
    Ortmeier, Brian
    Kricorian, Greg
    Wade, Sally
    Stolshek, Bradley
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB163 - AB163
  • [38] COMPARING DERMATOLOGY LIFE QUALITY INDEX (DLQI) BETWEEN MODERATE-TO-SEVERE ATOPIC DERMATITIS PATIENTS AND MODERATE-TO-SEVERE PSORIASIS PATIENTS
    Kim, Yeong Ho
    Yoo, Seung Ah
    Han, Ju Hee
    Lee, Ji Hae
    Bang, Chul Hwan
    Lee, Young Bok
    Kim, Jung Eun
    Park, Hyun Jung
    Park, Chul Jong
    Lee, Ji Hyun
    Cho, Sang Hyun
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 20 - 20
  • [39] WORK PRODUCTIVITY IN BRAZILIAN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS
    Lopes, N.
    Antonio, J. R.
    Fabricio, L.
    Azulay-Abulafia, L.
    Dias, L. L.
    Pertel, P.
    VALUE IN HEALTH, 2017, 20 (09) : A902 - A902
  • [40] Pattern of response in patients with moderate-to-severe psoriasis treated with etanercept
    Griffiths, C. E. M.
    Sterry, W.
    Brock, F.
    Dilleen, M.
    Stefanidis, D.
    Germain, J. M.
    Mallbris, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (01) : 230 - 238
12345